Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 55.28%
March 31, 2026 54.45%
December 31, 2025 64.54%
September 30, 2025 60.00%
June 30, 2025 63.81%
March 31, 2025 68.45%
December 31, 2024 63.39%
September 30, 2024 60.04%
June 30, 2024 58.65%
March 31, 2024 56.39%
December 31, 2023 57.23%
September 30, 2023 58.95%
June 30, 2023 62.22%
March 31, 2023 51.21%
December 31, 2022 57.59%
September 30, 2022 55.79%
June 30, 2022 46.76%
March 31, 2022 50.77%
December 31, 2021 54.78%
September 30, 2021 44.96%
June 30, 2021 38.69%
March 31, 2021 40.31%
December 31, 2020 15.98%
September 30, 2020 34.87%
June 30, 2020 20.51%
Date Value
March 31, 2020 34.43%
December 31, 2019 39.45%
September 30, 2019 26.15%
June 30, 2019 20.49%
March 31, 2019 13.57%
December 31, 2018 18.33%
September 30, 2018 -0.52%
June 30, 2018 -14.12%
March 31, 2018 -23.73%
December 31, 2017 10.53%
September 30, 2017 -11.44%
June 30, 2017 22.72%
March 31, 2017 -0.14%
December 31, 2016 4.84%
September 30, 2016 -31.14%
June 30, 2016 17.21%
March 31, 2016 -4.55%
December 31, 2015 -34.90%
September 30, 2015 -129.4%
June 30, 2015 -7.29%
March 31, 2015 48.37%
December 31, 2014 69.34%
September 30, 2014 -87.62%
June 30, 2014 72.84%
March 31, 2014 81.97%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 64.07%
Neogen Corp. 37.59%
QuidelOrtho Corp. 35.75%
VolitionRX Ltd. 28.37%
Lucid Diagnostics, Inc. -13.23%

Gross Profit Margin (Quarterly) Related Metrics